Microtubules-interfering agents restrict aryl hydrocarbon receptor-mediated CYP1A2 induction in primary cultures of human hepatocytes via c-jun-N-terminal kinase and glucocorticoid receptor

European Journal of Pharmacology

Volumn 581, Issue 3, 2008, Pages 244-254

  Vrzal, Radim ^a   Daujat Chavanieu, Martine ^b   Pascussi, Jean Marc ^b   Ulrichova, Jitka ^a   Maurel, Patrick ^b   Dvorak, Zdenek ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b INSERM   (France)

Author keywords

Aryl hydrocarbon receptor; Cytoskeleton; Glucocorticoid receptor; Human hepatocytes; MAPK kinases

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; COLCHICINE; CYCLOHEXIMIDE; CYTOCHROME P450 1A2; GLUCOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NOCODAZOLE; PACLITAXEL; STRESS ACTIVATED PROTEIN KINASE; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LIVER CELL; MALE; MICROTUBULE; PRIORITY JOURNAL; PROTEIN CONTENT;

CELL CYCLE; CELLS, CULTURED; CYTOCHROME P-450 CYP1A2; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICROTUBULES; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUBULIN MODULATORS;

EID: 39149134269     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.11.059     Document Type: Article

References (31)

1. Abbott B.D., Schmid J.E., Brown J.G., Wood C.R., White R.D., Buckalew A.R., and Held G.A. RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol. Sci. 47 (1999) 76-85
2. Aluru N., and Vijayan M.M. beta-naphthoflavone disrupts cortisol production and liver glucocorticoid responsiveness in rainbow trout. Aquat. Toxicol. 67 (2004) 273-285
3. Bogoyevitch M.A., Ketterman A.J., and Sugden P.H. Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J. Biol. Chem. 270 (1995) 29710-29717
4. Bonzo J.A., Chen S., Galijatovic A., and Tukey R.H. Arsenite inhibition of CYP1A1 induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin is independent of cell cycle arrest. Mol. Pharmacol. 67 (2005) 1247-1256
5. Dvorak Z., Maurel P., Ulrichova J., and Modriansky M. Microtubule disarray in primary cultures of human hepatocytes inhibits transcriptional activity of the glucocorticoid receptor via activation of c-jun N-terminal kinase. Biomed. Pap. Med. Fac. Palacky Univ. Olomouc Czech Repub. 148 (2004) 135-139
6. Dvorak Z., Modriansky M., Pichard-Garcia L., Balaguer P., Vilarem M.J., Ulrichova J., Maurel P., and Pascussi J.M. Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. Mol. Pharmacol. 64 (2003) 160-169
7. Dvorak Z., Modriansky M., Ulrichova J., Maurel P., Vilarem M.J., and Pascussi J.M. Disruption of microtubules leads to glucocorticoid receptor degradation in HeLa cell line. Cell. Signal. 17 (2005) 187-196
8. Dvorak Z., Vrzal R., Ulrichova J., Pascussi J.M., Maurel P., and Modriansky M. Involvement of cytoskeleton in AhR-dependent CYP1A1 expression. Curr. Drug. Metab. 7 (2006) 301-303
9. Galigniana M.D., Housley P.R., DeFranco D.B., and Pratt W.B. Inhibition of glucocorticoid receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton. J. Biol. Chem. 274 (1999) 16222-16227
10. Galigniana M.D., Radanyi C., Renoir J.M., Housley P.R., and Pratt W.B. Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus. J. Biol. Chem. 276 (2001) 14884-14889
11. Galigniana M.D., Scruggs J.L., Herrington J., Welsh M.J., Carter-Su C., Housley P.R., and Pratt W.B. Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Mol. Endocrinol. 12 (1998) 1903-1913
12. Harrell J.M., Murphy P.J., Morishima Y., Chen H., Mansfield J.F., Galigniana M.D., and Pratt W.B. Evidence for glucocorticoid receptor transport on microtubules by dynein. J. Biol. Chem. 279 (2004) 54647-54654
13. Isom H.C., Secott T., Georgoff I., Woodworth C., and Mummaw J. Maintenance of differentiated rat hepatocytes in primary culture. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 3252-3256
14. Joiakim A., Mathieu P.A., Palermo C., Gasiewicz T.A., and Reiners Jr. J.J. The Jun N-terminal kinase inhibitor SP600125 is a ligand and antagonist of the aryl hydrocarbon receptor. Drug. Metab. Dispos. 31 (2003) 1279-1282
15. Krstic M.D., Rogatsky I., Yamamoto K.R., and Garabedian M.J. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17 (1997) 3947-3954
16. Linder M.W., Falkner K.C., Srinivasan G., Hines R.N., and Prough R.A. Role of canonical glucocorticoid responsive elements in modulating expression of genes regulated by the arylhydrocarbon receptor. Drug. Metab. Rev. 31 (1999) 247-271
17. Mathis J.M., Prough R.A., and Simpson E.R. Synergistic induction of monooxygenase activity by glucocorticoids and polycyclic aromatic hydrocarbons in human fetal hepatocytes in primary monolayer culture. Arch. Biochem. Biophys. 244 (1986) 650-661
18. Maurel P. The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man. Adv. Drug Deliv. Rev. 22 (1996) 105-132
19. Pascussi J.M., Dvorak Z., Gerbal-Chaloin S., Assenat E., Maurel P., and Vilarem M.J. Pathophysiological factors affecting CAR gene expression. Drug. Metab. Rev. 35 (2003) 255-268
20. Pascussi J.M., Gerbal-Chaloin S., Pichard-Garcia L., Daujat M., Fabre J.M., Maurel P., and Vilarem M.J. Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem. Biophys. Res. Commun. 274 (2000) 707-713
21. Pichard-Garcia L., Gerbal-Chaloin S., Ferrini J.B., Fabre J.M., and Maurel P. Use of long-term cultures of human hepatocytes to study cytochrome P450 gene expression. Methods Enzymol. 357 (2002) 311-321
22. Pollenz R.S. The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem. Biol. Interact. 141 (2002) 41-61
23. Pollenz R.S., and Buggy C. Ligand-dependent and -independent degradation of the human aryl hydrocarbon receptor (hAHR) in cell culture models. Chem. Biol. Interact. 164 (2006) 49-59
24. Pollenz R.S., Wilson S.E., and Dougherty E.J. Role of endogenous XAP2 protein on the localization and nucleocytoplasmic shuttling of the endogenous mouse Ahb-1 receptor in the presence and absence of ligand. Mol. Pharmacol. 70 (2006) 1369-1379
25. Pratt W.B., Galigniana M.D., Harrell J.M., and DeFranco D.B. Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement. Cell. Signal. 16 (2004) 857-872
26. Rogatsky I., Logan S.K., and Garabedian M.J. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2050-2055
27. Santini R.P., Myrand S., Elferink C., and Reiners Jr. J.J. Regulation of Cyp1a1 induction by dioxin as a function of cell cycle phase. J. Pharmacol. Exp. Ther. 299 (2001) 718-728
28. Scholler A., Hong N.J., Bischer P., and Reiners Jr. J.J. Short and long term effects of cytoskeleton-disrupting drugs on cytochrome P450 Cyp1a-1 induction in murine hepatoma 1c1c7 cells: suppression by the microtubule inhibitor nocodazole. Mol. Pharmacol. 45 (1994) 944-954
29. Tan Z., Chang X., Puga A., and Xia Y. Activation of mitogen-activated protein kinases (MAPKs) by aromatic hydrocarbons: role in the regulation of aryl hydrocarbon receptor (AHR) function. Biochem. Pharmacol. 64 (2002) 771-780
30. Tan Z., Huang M., Puga A., and Xia Y. A critical role for MAP kinases in the control of Ah receptor complex activity. Toxicol. Sci. 82 (2004) 80-87
31. Whitesell L., and Cook P. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol. Endocrinol. 10 (1996) 705-712